1Takuhito S,Hidenori K,Shinya F.Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients[J].J Atheroscler Thromb,2005,12(6):344-352.
2Wang K,Zhou XR,Zhou ZM.Platelet,not endothelial,P-selectin is required for neointimal formation after vascular injury[J].Arterioscler Thromb Vasc Biol,2005,25(8):1584-1589.
3Seitaro O,Shosaku N,Akira S.Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy[J].Nephron,1999,81(3):271-277.
4Salah A,Medhat S.P-selectin levels in dibetes mellitus patients with coronary artery disease[J].Hematology,2005,10(3),183-187.
5Nagata K,Tsuji T,Todoroki N.Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62)[J].J Immunol,1993,151(6):3267-3273.
6Vandana S,Wolfgang B,Heather A.Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo:role of P-selectin[J].Blood,2005,106(7):2334-2339.
7Thorsten K,Elif E,Xuan D,et al.Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation[J].Basic Res Cardiol,2007,102(5):460-466.
8Geng JG,Chen M,Chou KC.P-selectin cell adhesion molecule in inflammation,thrombosis,cancer growth and metastasis[J].Current Med Chem,2004,11(16):2153-2160.
9Bavbek A,Kargili O.Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients:are they markers of vascular disease and diabetic nephropathy[J].Clin Appl Thromb Hemost,2007,13(4):391.
1Celermajer DS, Sorensen KE, Gooch NM, et al. Non-invasive detection of endothelial dysfunction in child and adults at risk of atherosclerosis. Lancet, 1992,340 : 1111-1115.
2Baron AD, Quon MJ. Insulin action and endothelial function. In: Reaven GM, Laws A. Insulin resistance, the metabolic syndrome X. Totowa Human Press, 1999 : 247-266.
3Anderson AD, Uehata A,Gerhard MD, et al. Close relationship of endothelial function in the human coronary and peripheral circulations. J Am Coil Cardiol, 1995,26 : 1235-1241.
4Devaraj S,Chan Ar Jr,Jialal I. Alpha-tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients. Diabetes Care, 2002,25: 524-529.
5Cleland SJ, Petrie JR, Shinichiro U, et al. Insulin-mediated vasodilation and glucose uptake are functionally linked in humans. Hypertension, 1999,33(part Ⅱ):554-558.
6Kuboki K ,Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and In vivo:a specific vascular action of insulin. Circulation, 2000,101 : 676-681.
7Utsumi K, Kawabe M,Hirama A,et al. Effects of selective LDL apheresis on plasma concentrations of ICAM-1 VCAM-1 and Pselectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis [J].Clin Chim Acta, 2007, 377(1:2) :198-200.
8Butler AE, J anson J,Bonner-Weir S,et al. Beta-cell deficit and in creased beta-cell apoptosis in humans wit h type 2 diabetes[J]. Diabetes,2003,52(1) :102- 110.
2The American College of Cardiology Foundation and the American Heart Association. ACC/AHA guidelines for the management of patients with peripheral arterial disease [ J]. Circulation, 2006, 113 (11) : e463 - e654.
3Tan K T, Tayebjee N H, Lira H S, etal. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet micropartiele levels[ J]. Diabet Ned, 2005, 22(12) : 1657 - 1662.
4Aref S, Sakrana M, Hafez A A, et al. Soluble P-selectin levels in dia betes mellitus patients with coronary artery disease [ J]. Hematology, 2005, 10(3): 183-187.
5Theuma P, Fonseca V A. Inflammation, insulin resistance, and atherosclerosis[ J]. Metab Syndr Relat Disord, 2004, 2(2) : 105 -113.
6杨进刚,王建旗,李觉.外周动脉疾病诊疗指南[M].上海:同济大学出版社,2006,42.
7Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with im- paired glucose tolerance: the STOP-NIDDM trial [ J ]. JAMA, 2003,290(4) :486-494.
8Hanefeld M, Chiasson JL, Koehler C, et al. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance [ J ]. Stroke, 2004,35 ( 5 ) : 1073- 1078.
9Hanefeld M, Cagatay M, Petrowitsch T, et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analy- sis of seven long-term studies[J]. Eur Heart J, 2004,25 ( 1 ) : 10- 16.
10Derosa G, Maffioli P. Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review[J]. Clin Ther, 2012,34(6) :1221-1236.
